Impact of cancer cachexia on the course of chemotherapy in patients with advanced lung cancer

被引：0
|
作者：
Khezami, N. [1 ]
Bachouch, I. [1 ]
Bouguerra, K. [1 ]
Mrassi, H. [1 ]
Zargouni, A. [1 ]
Belloumi, N. [1 ]
Habouria, C. [1 ]
Chermiti, F. [1 ]
Fenniche, S. [1 ]
机构：
[1] Abderrahmen Mami Hosp, Dept Pulmonol, Pavil 4, Ariana, Tunisia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4158
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4158
引用
收藏
页数：2
相关论文
共 50 条
  • [31] THE EFFECT OF CACHEXIA ON SURVIVAL IN LUNG CANCER PATIENTS
    Shah, S.
    Noone, J. M.
    Blanchette, C. M.
    Arthur, S.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A96 - A96
  • [32] CACHEXIA AND LUNG CANCER
    Milroy, Robert
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S80 - S80
  • [33] Pulmonary Rehabilitation in Advanced Lung Cancer Patients During Chemotherapy
    Jastrzebski, D.
    Maksymiak, M.
    Kostorz, S.
    Bezubka, B.
    Osmanska, I.
    Mlynczak, T.
    Rutkowska, A.
    Baczek, Z.
    Ziora, D.
    Kozielski, J.
    [J]. RESPIRATORY HEALTH, 2015, 861 : 57 - 64
  • [34] Evaluating Survival Outcome for Chemotherapy in Advanced Lung Cancer Patients
    Lin, PeiYi
    Lin, MeiFan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 417 - 418
  • [35] CHEMOTHERAPY IN ADVANCED LUNG-CANCER
    FLEISCHER, I
    WAINSTEIN, R
    JOVTIS, SL
    GIBSON, AM
    BAROUSSE, AP
    [J]. MEDICINA-BUENOS AIRES, 1979, 39 (04) : 472 - 476
  • [36] "Metabolic fingerprints" of cachexia in lung cancer patients
    Frille, Armin
    Arends, Jann
    Abenavoli, Elisabetta M.
    Duke, Shaul A.
    Ferrara, Daria
    Gruenert, Stefan
    Hacker, Marcus
    Hesse, Swen
    Hofmann, Lukas
    Holm, Sune H.
    Lund, Thomas B.
    Rullmann, Michael
    Sandoe, Peter
    Sciagra, Roberto
    Sundar, Lalith Kumar Shiyam
    Toenjes, Anke
    Wirtz, Hubert
    Yu, Josef
    Sabri, Osama
    Beyer, Thomas
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (07) : 2067 - 2069
  • [37] Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors
    Luis Izquierdo, Jose
    Resano, Pilar
    El Hachem, Abdulkader
    Graziani, Desire
    Almonacid, Carlos
    Sanchez, Ignacio M.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 1053 - 1058
  • [38] Altered fibrin clot properties in advanced lung cancer: impact of chemotherapy
    Krolczyk, Grzegorz
    Zabczyk, Michal
    Czyzewicz, Grzegorz
    Plens, Krzysztof
    Prior, Shannon
    Butenas, Saulius
    Undas, Anetta
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6863 - 6872
  • [39] Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes
    Rhys White
    C. Elizabeth Weekes
    Robert Grant
    Christine Baldwin
    Hafez Ahmed
    [J]. Supportive Care in Cancer, 2020, 28 : 4373 - 4380
  • [40] Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes
    White, Rhys
    Weekes, C. Elizabeth
    Grant, Robert
    Baldwin, Christine
    Ahmed, Hafez
    [J]. SUPPORTIVE CARE IN CANCER, 2020, 28 (09) : 4373 - 4380
12345